|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL.: (2024.01) |
A61K 36/28 A61K 31/00 |
| (11) | Number of the document | 7102 |
| (13) | Kind of document | B |
| (21) | Application number | 2023 508 |
| (22) | Date of filing the application | 2023-02-08 |
| (41) | Date of publication of the application | 2024-08-12 |
| (45) | Date of publication of patent | 2024-10-25 |
| (71) |
YUNNAN BIOVALLEY PHARMACEUTICAL CO., LTD.,
No. 999, Bio Valley Street, Majinpu New District, High tech Zone, 650500 Kunming, Yunnan,
CN
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Tiantan Xili, Dongcheng District, 100050 Beijing, CN |
| (72) |
Yanhe LIN, CN
Jiandong JIANG, CN Lulu WANG, CN |
| (73) |
YUNNAN BIOVALLEY PHARMACEUTICAL CO., LTD.,
No. 999, Bio Valley Street, Majinpu New District, High tech Zone, 650500 Kunming, Yunnan,
CN
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Tiantan Xili, Dongcheng District, 100050 Beijing, CN |
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | ORAL PREPARATION CONTAINING ERIGERON BREVISCAPUS EXTRACT, AND PREPARATION METHOD AND APPLICATION OF ORAL PREPARATION |
| Payment date | Validity (years) | Amount | |
| 2026-01-02 | 4 | 92.00 EUR |
| 2027-02-08 |